Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide.
Hrycek
A
A
Kokocińska
D
D
Kośmider
J
J
Konieczny
B
B
D000328:Adult; D000634:Aminoquinolines / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D002986:Clinical Trials as Topic; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D008875:Middle Aged; D010455:Peptides / Q000097:blood / Q000276:immunology*; D012720:Severity of Illness Index
D000634:Aminoquinolines; D014408:Biomarkers, Tumor; D018491:Dopamine Agonists; D010455:Peptides; C089984:tissue polypeptide specific antigen; C046650:quinagolide